Literature DB >> 33453141

Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.

Anoop N Koshy1,2, Paul J Gow2,3, Adam Testro2,3, Andrew W Teh1,2, Jefferson Ko1, Han S Lim1,2, Hui-Chen Han1,2, Laurence Weinberg2,4, Lisa B VanWagner5, Omar Farouque1,2.   

Abstract

It is postulated that cardiac structural abnormalities observed in cirrhotic cardiomyopathy (CCM) contribute to the electrophysiologic abnormality of QT interval (QTc) prolongation. We sought to evaluate whether QTc prolongation is associated with intrinsic abnormalities in cardiac structure and function that characterize CCM. Consecutive patients undergoing liver transplant work-up between 2010 and 2018 were included. Measures of cardiac function on stress testing including cardiac reserve and chronotropic incompetence were collected prospectively and a corrected QTc ≥ 440 ms was considered prolonged. Overall, 439 patients were included and 65.1% had a prolonged QTc. There were no differences in markers of left ventricular and atrial remodeling, or resting systolic and diastolic function across QTc groups. The proportion of patients that met the criteria for a low cardiac reserve (39.2 vs 36.6%, p = .66) or chronotropic incompetence (18.1 vs 21.3%, p = .52) was not different in those with a QTc ≥ 440 vs <440 ms. Further, there was no association between QTc prolongation and CCM by either the 2005 World College of Gastroenterology or modified 2020 Cirrhotic Cardiomyopathy Consortium criteria. QT interval prolongation was not associated with structural or functional cardiac abnormalities that characterize CCM. These findings suggest that CCM and QT interval prolongation in cirrhosis may be two separate entities with distinct pathophysiological origins.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  cardiovascular disease; cirrhosis; clinical research/practice; complication: medical/metabolic; diagnostic techniques and imaging: echocardiography; liver transplantation/hepatology; translational research/science

Mesh:

Year:  2021        PMID: 33453141      PMCID: PMC8819736          DOI: 10.1111/ajt.16500

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   9.369


  28 in total

Review 1.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03       Impact factor: 6.875

2.  Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.

Authors:  Anoop N Koshy; Paul J Gow; Hui-Chen Han; Andrew W Teh; Robert Jones; Adam Testro; Han S Lim; Geoffrey McCaughan; Gary P Jeffrey; Michael Crawford; Graeme Macdonald; Jonathan Fawcett; Alan Wigg; John W C Chen; Edward J Gane; Stephen R Munn; David J Clark; Matias B Yudi; Omar Farouque
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2020-10-01

3.  Prediction of Perioperative Cardiovascular Events in Liver Transplantation.

Authors:  Anoop N Koshy; Omar Farouque; Benjamin Cailes; Jefferson Ko; Hui-Chen Han; Laurence Weinberg; Adam Testro; Marcus Robertson; Andrew W Teh; Han S Lim; Paul J Gow
Journal:  Transplantation       Date:  2021-03-01       Impact factor: 4.939

Review 4.  Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander.

Authors:  Manhal Izzy; Jae Oh; Kymberly D Watt
Journal:  Hepatology       Date:  2018-10-13       Impact factor: 17.425

5.  Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy.

Authors:  C A Ward; H Liu; S S Lee
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

Review 6.  Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.

Authors:  Signe Wiese; Jens D Hove; Flemming Bendtsen; Søren Møller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-12       Impact factor: 46.802

7.  Impact and persistence of cirrhotic cardiomyopathy after liver transplantation.

Authors:  Abraham Sonny; Ahmed Ibrahim; Andres Schuster; Wael A Jaber; Jacek B Cywinski
Journal:  Clin Transplant       Date:  2016-07-08       Impact factor: 2.863

Review 8.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

9.  Effect of QT interval prolongation on cardiac arrest following liver transplantation and derivation of a risk index.

Authors:  Anoop N Koshy; Jefferson Ko; Omar Farouque; Shamil D Cooray; Hui-Chen Han; Benjamin Cailes; Paul J Gow; Laurence Weinberg; Adam Testro; Han S Lim; Andrew W Teh
Journal:  Am J Transplant       Date:  2020-07-05       Impact factor: 8.086

Review 10.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.